Empire State Review Contributor 
BETHESDA, MD — On June 9, 2025, the National Institutes of Health (NIH) released a comprehensive report detailing significant advancements in medical robotics aimed at enhancing patient care. The report underscores the transformative potential of robotic technologies in various healthcare domains, including surgery, rehabilitation, and elder care.
One of the key areas highlighted is the development of surgical robots designed to assist in minimally invasive procedures. These robots can lead to reduced pain and blood loss, smaller scars, and quicker recovery times for patients. Researchers are also exploring the use of tiny robotic tools to help surgeons reach hard-to-access areas during operations.
In the realm of rehabilitation, the NIH supports studies on wearable robotics, such as battery-powered exoskeletons. These devices can aid individuals in moving existing limbs, potentially improving mobility and preventing falls, especially among older adults. Exoskeletons are designed to work in sync with the user’s muscles, reducing the effort required for movement.
The report also emphasizes the role of social robots in assisting individuals with dementia and their caregivers. These human-like, interactive robots can engage patients in conversations, play music, and encourage reminiscence, which may improve emotional well-being and quality of life. Additionally, they can provide caregivers with evidence-based information about dementia care, helping to reduce stress and promote health.
Furthermore, NIH-funded research is exploring the use of robotic technologies in various medical applications, such as:
- “Gripper” tools to assist individuals in maneuvering everyday items.
- Devices to monitor medication adherence.
- Head-mounted robotic technology to enhance delicate eye surgeries.
- Magnet-guided robots offering safer alternatives to standard colonoscopy.
- Robot-assisted correction of ankle bone fractures.
- Flexible robots to improve radiation therapy for breast cancer.
- Robotic “smart” needles to enhance accuracy in prostate cancer treatments.
These advancements reflect the NIH’s commitment to integrating cutting-edge technologies into healthcare to improve patient outcomes and quality of life.
